SCHEMBL12468232

SCHEMBL12468232

CCOc1c(F)cc(CC)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.39
HTR2C P28335 4/20 0.39
HTR1A P08908 3/20 0.39
DRD2 P14416 3/20 0.39
DRD4 P21917 3/20 0.39
DRD3 P35462 3/20 0.39
POLB P06746 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTR2B P41595 1/20 0.35
KMT2A Q03164 3/20 0.35
PTGS2 P35354 1/20 0.34
THRB P10828 2/20 0.34
MEN1 O00255 1/20 0.34
PKM P14618 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15109247 0.83 DRD2 (0.50) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL3841470 0.81 LMNA (0.40) HTR2AHTR2CPOLBLMNAHTT
SCHEMBL12504658 0.79 LMNA (0.39) POLBLMNAHTTALDH1A1KMT2A
SCHEMBL19354878 0.75 POLB (0.38) POLBLMNAHTTALDH1A1SMN1; SMN2
SCHEMBL12401802 0.75 CYP2C19 (0.39) LMNAHTTALDH1A1SMN1; SMN2NPC1
SCHEMBL14804141 0.75 SMN1; SMN2 (0.33) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL22484118 0.74 KDM4A (0.34) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL17069252 0.74 HTR2A (0.33) HTR2AHTR2CHTR1ADRD2DRD4
SCHEMBL17910956 0.74 LMNA (0.43) POLBLMNAHTTALDH1A1SMN1; SMN2
SCHEMBL2010577 0.74 ALDH1A1 (0.52) POLBLMNAHTTALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570090-B2 Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof SANOFI (FR) 2020-02-25 US disclosed
US-20180079720-A1 NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF SANOFI (FR) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570090-B2 Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof CYP19A1, ESR1, GPER1 HTR2A 1060/4885HTR2C 889/4885HTR1A 690/4885
US-20180079720-A1 NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF CYP19A1, ESR1, ESR2 HTR2A 1336/4885HTR2C 871/4885HTR1A 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.